Sleep Disturbances as a Non-Traditional Risk Factor in Chronic Kidney Disease- University of Illinois (CRIC)

This study has been completed.
Sponsor:
Collaborator:
University of Illinois at Chicago
Information provided by (Responsible Party):
University of Chicago
ClinicalTrials.gov Identifier:
NCT00817492
First received: January 5, 2009
Last updated: September 4, 2013
Last verified: September 2013

January 5, 2009
September 4, 2013
July 2006
June 2011   (final data collection date for primary outcome measure)
Sleep Quality [ Time Frame: Sleep Quality was determined after PSG on all subjects were completed ] [ Designated as safety issue: No ]
Not Provided
Complete list of historical versions of study NCT00817492 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Sleep Disturbances as a Non-Traditional Risk Factor in Chronic Kidney Disease- University of Illinois
Sleep Disturbances as a Non-Traditional Risk Factor in Chronic Kidney Disease

This study will help determine the relationship between impaired sleep and chronic kidney disease, specifically to determine if sleep disturbances are a risk factor for worsening kidney function.

Not Provided
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Renal Clinic patients at The University of Illinois at Chicago Hospital

Chronic Kidney Disease
Not Provided
  • 1
    Subjects with mild to moderate kidney disease
  • 2
    Healthy Control Subjects
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
89
June 2011
June 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • CKD subjects will be participants in a larger study, CRIC, at the University of Illinois, Chicago
  • 30 Healthy controls age and gender matched to 30 CKD subjects, regular bedtimes of at least 6h/night, sedentary lifestyle

Exclusion Criteria:

  • Diabetes
  • Current or previous dialysis for more than 1 month
  • Uncontrolled hypertension
  • Heart failure
  • Liver disease
  • HIV
  • Hemoglobin < 10.5 g/dl
  • Treatment with EProcrit, Epogen, or Aranesp
  • Bone or organ transplant,
  • Use of immunosuppressive drugs within past 6 months
  • Current oral contraceptive use
  • Current pregnancy
  • Chemotherapy for malignancy within past 2 years
Both
21 Years to 74 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00817492
#14747A, 5RO1DK071696
No
University of Chicago
University of Chicago
University of Illinois at Chicago
Principal Investigator: Eve Van Cauter, PhD University of Chicago
Principal Investigator: James Lash, MD University of Illinois at Chicago
University of Chicago
September 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP